Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 46.2B | 31.2B | 31.1B |
Cost of revenue | — | 27.6B | 11.1B | 15.5B |
Gross profit | — | 18.6B | 20.2B | 15.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | 9.4B | 13.9B | 9.8B |
Non operating interest income | ||||
Income | — | 380M | 242M | 336M |
Expense | — | 16M | 15M | 14M |
Other income expense | — | — | — | — |
Pretax income | — | 9.7B | 13.4B | 10.3B |
Tax provision | — | 947M | 4.1B | 3.2B |
Net income | — | 8.7B | 9.3B | 7.1B |
Basic EPS | 11.9 | — | — | — |
Diluted EPS | 11.9 | — | — | — |
Basic average shares | 836.5M | — | — | — |
Diluted average shares | 836.5M | — | — | — |
EBITDA | — | 11.2B | 14.4B | 11.3B |
Net income from continuing op. | — | 9.7B | 13.4B | 10.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | 0 | 0 | 0 |